ARCHIVES

NCI To Proceed With Guidelines Unless Board Strongly Disagree

This article is from The Cancer Letter archive.

Vol. 06 No. 19 | May 9, 1980

Download PDF Visit The Full Archive

Related Articles

NCCS Networker Volume 8 Issue 1, Spring 1994

April 13, 1994

Cancer Drugs Initiatives To Shorten approval Times, Ensure Post-Marketing Studies, FDA Official Says

April 26, 1996

Sen. Specter Vows to “Stay and Fight” For Health, Education, On Subcommittee.

February 11, 2005

NCI Cooperative Group, Cancer Center Trials Listed

July 27, 2007

Investigational Drug Radium-223 Chloride Improved Overall Survival By 44 Percent

September 30, 2011

Montefore Oncology Dept. Writes In Support of Peter Wiernik

November 12, 1993